Access Bio Dividends and Buybacks
Dividend criteria checks 2/6
Access Bio is a dividend paying company with a current yield of 15.83%.
Key information
15.8%
Dividend yield
-0.3%
Buyback Yield
| Total Shareholder Yield | 15.5% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | ₩823.000 |
| Payout ratio | n/a |
Recent dividend and buyback updates
Recent updates
Access Bio, Inc.'s (KOSDAQ:950130) Prospects Need A Boost To Lift Shares
Nov 13
Optimistic Investors Push Access Bio, Inc. (KOSDAQ:950130) Shares Up 38% But Growth Is Lacking
Aug 07Access Bio's (KOSDAQ:950130) Earnings Are Weaker Than They Seem
Mar 26Is Access Bio (KOSDAQ:950130) A Risky Investment?
Mar 25If You Had Bought Access Bio (KOSDAQ:950130) Shares A Year Ago You'd Have Earned 740% Returns
Feb 18Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, A950130 has been paying a dividend for less than 10 years.
Growing Dividend: A950130 has only been paying a dividend for 2 years, and since then payments have not increased.
Dividend Yield vs Market
| Access Bio Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A950130) | 15.8% |
| Market Bottom 25% (KR) | 1.2% |
| Market Top 25% (KR) | 4.0% |
| Industry Average (Medical Equipment) | 1.4% |
| Analyst forecast (A950130) (up to 3 years) | n/a |
Notable Dividend: A950130's dividend (15.83%) is higher than the bottom 25% of dividend payers in the KR market (1.24%).
High Dividend: A950130's dividend (15.83%) is in the top 25% of dividend payers in the KR market (4.01%)
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate A950130's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: A950130 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 15:48 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Access Bio, Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jongsun Park | Eugene Investment & Securities Co Ltd. |
| Gwang Sik Park | Kyobo Securities Co., Ltd |
| Kyung-Churl Noh | SK Securities Co., Ltd. |